| Literature DB >> 21702951 |
Hiroki Takahashi1, Takuya Morimoto, Naotake Ogasawara, Shigehiko Kanaya.
Abstract
BACKGROUND: Liquid chromatography-mass spectrometry (LC-MS) utilizing the high-resolution power of an orbitrap is an important analytical technique for both metabolomics and proteomics. Most important feature of the orbitrap is excellent mass accuracy. Thus, it is necessary to convert raw data to accurate and reliable m/z values for metabolic fingerprinting by high-resolution LC-MS.Entities:
Mesh:
Year: 2011 PMID: 21702951 PMCID: PMC3149581 DOI: 10.1186/1471-2105-12-259
Source DB: PubMed Journal: BMC Bioinformatics ISSN: 1471-2105 Impact factor: 3.307
Figure 1Illustration of AMDORAP outline. AMDORAP method consists of three steps. (a) Collect data points. (b) Group collected data by m/z closeness. (c) Extraction chromatograms for m/z list.
Figure 2Intensity distribution of LC-orbitrap data. B. subtilis strain 168 was measured using the LC-orbitrap in the positive mode. The centroid data has 1 694 959 data points, obtained with 1945 scans over 45 minutes (data size is 29 MB). (a) % of total variance. Each dot corresponds to the percent of variance explained by each corresponding percent of the data from 0.1-100 at interval of 0.1%. Red dot corresponds to the top 1% of the data, which explained 99.7% of the total variance. (b) Intensity distribution. All data points are plotted. Nine black horizontal solid lines correspond to 90th- 98th percentile values at interval of 1%, and the red line corresponds to the 99th percentile value.
Figure 3All data vs Top 1% of data. (a) The comparison of the total ion chromatograms of all and top 1% of data. The abscissa and ordinate axes correspond to the retention times and ion intensity, respectively. The total ion chromatograms of all data and top 1% of data were plotted as black and red solid lines, respectively. (b) Two dimensional map (m/z vs retention times). Top 1% of data are plotted as red points.
Figure 4Numbers of detected . Black (ordinate axis on the left) and red (ordinate axis on the right) dots correspond to the numbers of detected m/z values using 1 and 5% of the data, respectively.
Comparison of detected m/z values for fourteen compounds by AMDORAP, MZmine 2 and XCMS
| AMDORAP | MZmine 2 | XCMS | ||||||
|---|---|---|---|---|---|---|---|---|
| metabolite | formula | observed | error | observed | error | Observed | error | |
| serine | C3H7NO3 | 106.04987 | 106.04955 | -3.02 | 106.04958 | -2.68 | ||
| valine | C5H11NO2 | 118.08626 | 118.08602 | -2.01 | 118.08422 | -17.26 | ||
| glutamine | C5H10N2O3 | 147.07642 | 147.07666 | 1.64 | 147.14403 | 459.68 | ||
| lysine | C6H14N2O2 | 147.11280 | 147.11067 | -14.49 | 147.10871 | -27.82 | ||
| glutamic acid | C5H9NO4 | 148.06043 | 148.06055 | 0.76 | 148.05154 | -60.10 | ||
| methionine | C5H11NO2S | 150.05833 | 150.05817 | -1.06 | 150.04993 | -55.93 | ||
| D-alanyl-D-alanine | C6H12N2O3 | 161.09207 | 161.09181 | -1.59 | 161.08698 | -31.61 | ||
| phenylalanine | C9H11NO2 | 166.08626 | 166.08617 | -0.53 | 166.08285 | -20.50 | ||
| citrulline | C6H13N3O3 | 176.10297 | 176.10280 | -0.96 | 176.11662 | 77.51 | ||
| tyrosine | C9H11NO3 | 182.08117 | 182.08113 | -0.21 | 182.08110 | -0.41 | ||
| tryptophan | C11H12N2O2 | 205.09715 | 205.06284 | -167.29 | 205.09010 | -34.38 | ||
| pantothenate | C9H17NO5 | 220.11795 | 220.11414 | -17.29 | 220.12327 | 24.18 | ||
| uridine | C9H12N2O6 | 245.07681 | 245.10884 | 130.69 | 245.08308 | 25.58 | ||
| methylthioadenosine | C11H15N5O3S | 298.09684 | 298.08231 | -48.72 | 298.09719 | 1.18 | ||
Comparison of detected m/z values between AMDORAP, MZmine 2 and XCMS. Seven m/z values obtained by AMDORAP, i.e., serine, valine, lysine, tryptophan, pantothenate, uridine and methylthioadenosine, were closest to the theoretical masses.
Figure 5A chromatogram trace of phenylalanine. Chromatogram trace of m/z slice 166.08534-166.08700 is presented. Black solid and red dashed lines correspond to B. subtilis strains 168 and MGB874, respectively. Two peak areas were also observed for an authentic compound under our conditions.